Author

K. M. Taufiqur Rahman

South Dakota State UniversityORCID 0000-0001-6389-1013Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Abhyudai SinghiD· 1 shared Md Morsaline BillahiD· 1 shared Md. Fahmid IslamiD· 1 shared Nicholas C. ButziniD· 1 shared Ruqayyah Amaratunga· 1 shared Sanjib SahaiD· 1 shared Tahmina HossainiD· 1 shared Xuan Yi ButziniD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abhyudai SinghORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyInternational Journal of Antimicrobial AgentsPeer-reviewedNov 15, 2024

Rethinking Dormancy: Antibiotic Persisters are Metabolically Active, Non-Growing Cells

K. M. Taufiqur Rahman, Ruqayyah Amaratunga, Xuan Yi Butzin…·Nicholas C. Butzin

This study challenges the idea that antibiotic persisters are metabolically dormant by showing that Escherichia coli persisters remain metabolically active and exhibit dynamic gene expression changes.

24 citationstop 3%

E. colibulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMar 21, 2021

The Central Importance of Hub Proteins in a Disease-Gene Network Model: A New Paradigm of Chronic Myeloid Leukemia Disease Study

K. M. Taufiqur Rahman, Md. Fahmid Islam, Sanjib Saha, Md Morsaline Billah

The paper identifies hub proteins in a disease-gene network model for chronic myeloid leukemia (CML) and suggests potential drug targets.

DOI 10.1101/2021.03.21.436331

humanproteomics

𝕏 PostBluesky